|
|
Press Releases |
|
| More information |
| Hadassah Researchers and Dor Yeshorim Identify Gene Responsible for Joubert Syndrome | | 28/12/2009 | Researchers at the Hadassah University Medical Center, together with Dor Yeshorim (The Committee for the Prevention of Jewish Genetic Diseases) have announced the discovery of a genetic mutation that causes children of Ashkenazi Jews to be born with Joubert Syndrome, a neurological genetic disease. Their findings will be published in the January 2010 edition of The American Journal of Human Genetics. This is the 13th gene whose mutations may cause the birth of children with genetic diseases Hadassah’s Department of Genetics and Metabolic Diseases discovered during the last two years. |
|
| Hadassah and Desert Labs Researchers Demonstrate that Cactus Extract Alleviates Symptoms of Metabolic Syndrome and Fatty Liver Disease | | 03/11/2009 | Jerusalem - Researchers at the Hadassah University Medical Center have demonstrated that – when administered orally for a month – the frozen natural extract of the succulent plant Hoodia Parviflora decreases the level of sugar in the blood and improves the symptoms of metabolic syndrome in patients with fatty liver disease. This is the first time this plant’s extract proved to efficiently decrease the level of fat in the liver and the first time scientists succeeded in improving symptoms of fatty liver disease using natural materials, in addition to the plant’s appetite suppressing properties. |
|
| Positive Results of Hadassah-Alcobra Ltd Phase 1 Clinical Trial of | | 01/11/2009 | A Phase 1 clinical trial conducted at the Hadassah University Hospital-Ein Kerem showed that ingesting one dose of a new slow release Metadoxine formula before consuming alcohol lowered the level of alcohol in the blood, dramatically improved motor and cognitive functions and decreased the craving for alcohol in the test participants. Metadoxine, a substance currently used to treat alcoholic addiction, is only effective for about 50 minutes. The slow release formula was developed by Alcobra Ltd., an Israeli start-up company. |
|
| Hadassah Researchers Discover Treatment for Fatty Liver Disease | | 01/11/2009 | Jerusalem - Hadassah researchers have demonstrated that Colostrum, the milk produced by cows immediately after calving, enriched with insulin antibodies, dramatically lowers the level of sugar and insulin resistance in mice with a model of fatty liver disease. They treated mice with fatty liver disease with Colostrum enriched with insulin antibodies, administered orally for four weeks, which showed positive results. |
|
| Hadassah Receives Generous Gift for the Sarah Wetsman Davidson Tower | | 11/10/2009 | The Hadassah University Medical Center has announced a generous gift from the David and Fela Shapell Family Foundation of Beverly Hills, California for the Entrance Atrium to the Sarah Wetsman Davidson Tower, currently under construction on Hadassah’s Ein Kerem campus in Jerusalem. |
|
| Completion of Transfer of Oral Immunotherapy Patent to Immuron. | | 09/09/2009 | Immuron and Hadasit are pleased to announce the completion of the acquisition of intellectual property (IP) by Immuron from Hadasit in the area of oral immunotherapies, and the establishment of Hadasit as the largest shareholder in Immuron, with a 19.99% stake. The initial applications of the technology platform associated with this IP will be type 2 diabetes, liver cancer (hepatoma), and hepatitis C. |
|
| Jessa's Story | | 16/08/2009 | Jessa Perin (16) is from Cincinnati. She came to Israel with Birthright last July. On Tuesday July 19, while touring in the north with her group, Jessa became very sick with no visible reason. Her condition deteriorated rapidly and she was taken to a hospital in northern Israel. While Israeli members of her family were trying to find out if she could be transferred to Hadassah, the hospital in the north consulted with Hadassah Ein Kerem regarding the best thing for her. Dr. Rifat Safadi from Hadassah's liver unit decided that she had to be taken to Hadassah immediately, and this happened the same night.Upon arrival, Jessa underwent a series of tests which showed very clearly that she was in real danger unless she was undergoing a liver transplantation. |
|
| Hadassah Medical Center in Jerusalem mourns the death of Bill Davidson in Detroit | | 15/03/2009 | Hadassah Medical Center in Jerusalem mourns the death of Bill Davidson in Detroit . Davidson was one of Hadassah's strongest supporters. Together with his wife Karen, he made a very significant contribution to the establishment of the new Sarah Wetsman Davidson Hospitalization Tower in the Hadassah Ein- Kerem Campus.
|
|
| Prime Minister Ehud Olmert came to visit the Hadassah children for Purim | | 11/03/2009 | The children (and their parents) and the nurses were already waiting when the PM arrived. He was welcomed by Prof. Mor-Yosef and Dr. Yuval Weiss, director of Ein-Kerem hospital. PM Olmert, brought gifts (Mishlo'ach Manot) to the children, and sat among them for half an hour. Ephraim Der'i, father of Hadassah Der'I (2 years old) was very excited when he told that his daughter's life was saved by Hadassah physicians, after no one could diagnose the disease she was suffering from. He said they were hoping to go back home in a few days, and that little Hadassah was celebrating her birthday today. But she was not the only Hadassah who was celebrating a birthday in Purim. We prepared a special cake with greeting in Hebrew: "Hadassah celebrates its 97th birthday", and PM Olmert cut the slices and tasted it with the children. |
|
| Israel lags in race for medical tourists | | 01/03/2009 | "Proper handling of Medical Tourism will bring to Israel much income and foreign currency, improve our status in the world, and especially in the region, contribute to the creation of new jobs, increase the satisfaction of doctors and contribute to their remaining in Israel. All this will raise the level of medicine in Israel," said Prof. Shlomo Mor-Yosef. |
|
| Successful Stage II Clinical Trials for New Medication | | 25/08/2008 | A new medication to treat Cystic Fibrosis (CF) has successfully passed the Stage II clinical trials conducted at Jerusalem’s Hadassah University Medical Center. Developed by PTC Therapeutics of South Plainfield, NJ, the experimental treatment energizes the production of a deficient protein, causing it to return to its proper function. The successful results, published in the August 21 edition of the prestigious medical journal The Lancet, immediately attracted international attention. |
|
| We do not wait for the future | | 30/07/2008 | Before-and-after videoclips are the best way to impress people about what cutting-edge medicine can do. And this is what happened with the 2,000 delegates to the 94th national convention of Hadassah Women's Zionist Organization of America, held recently in Los Angeles. The Hadassah Medical Organization - the main beneficiary of HWZOA's generous fundraising - sent half-a-dozen senior physicians to update the delegates about two Israeli medical centers' recent achievements. |
|
| First Heart-lung Machine of its Type in Israel Acquired by Hadassah | | 19/06/2008 | To provide the most advanced surgical care, Hadassah’s Department of Cardio-Thoracic Surgery has been acquiring sophisticated equipment and instruments, including a state-of-the-art heart-lung machine that can observe coagulation antibodies – the only machine of its kind in Israel. The new machine is better suited to the human body’s physiological system so that the patient experiences far fewer adverse side affects. Other new equipment allows the Department to expand its minimally-invasive surgical procedures. More than 700 new items have been purchased in recent months. |
|
| Hadassah University Medical Center Launches Air Ambulance Service for Emergency Evacuation | | 10/06/2008 | Hadassah launches today a new air evacuation service for emergency patients from the Middle East and Eastern Europe. The project will operate in cooperation with ” iMER”, Hadassah’s medical tourism agent and Hadassah’s Emergency Medicine Department, and with “Orange Aviation”, that specializes in executive air transportation. The goal of the new venture is widening the spectrum of services for medical tourists and increasing revenues to the hospital. |
|
| The 60 year events in memory of the Hadassah convoy | | 06/04/2008 | The State Memorial Ceremony in commemoration of the Hadassah Convoy. The ceremony will take place in the presence of the minister of health, Mr. Yaakov Ben Yizri, in the Convoy Garden, in the Hadassah Mt. Hospital. Scopus. |
|
| New studies in the biological psychiatry unit, psychiatric department at Hadassah Ein-Kerem Medical center | | 05/03/2008 | Transcranial Magnetic Stimulation (TMS) Treatment for Post Traumatic Stress Disorder (PTSD) and Depression .
TMS is a non-invasive brain stimulation technique which has been used worldwide as an investigational and therapeutic tool over 10 years. In TMS, alternating magnetic field is produced by a coil held in proximity to the patient's head. This magnetic field induces electrical activity in relatively superficial brain regions underneath the coil. Deep TMS makes use of newly developed coils to stimulate deeper brain regions involved in mood disorders and in PTSD. In addition, the enrollment for the study in Depression is still ongoing and people (18-70) suffering from medication-resistant Depression are invited to call. Positive interim results have been found in this study. |
|
| Global Breakthrough at Hadassah | | 01/03/2008 | Viable Pregnancy Achieved In Woman Who Carries the Defective BRCA2 Genes After In-Vitro Fertilized Embryos Are Tested and Implanted. |
|
| New Orally Administered Therapy for Autoimmune Diseases. | | 23/01/2008 | A Phase I safety and efficacy study in healthy patients will begin in February 2008 at Hadassah University Medical Center in Jerusalem.
Jerusalem, Israel and Boston, Massachusetts, Tuesday, January 22, 2008 --- Hadasit, the technology transfer company of Hadassah Medical Organization in Jerusalem, Harvard Medical School (HMS) and Brigham and Women’s Hospital (BWH), a teaching affiliate of Harvard Medical School, announced today an equally owned joint scientific venture to develop a new orally administered therapeutic treatment for autoimmune diseases. The new product is a combination therapy that joins together both Hadasit and BWH/HMS intellectual property. This is the first official cooperation between Hadasit, Hadassah, Harvard Medical School and Brigham and Women’s Hospital. |
|
| Open Hearts at Hadassah | | 28/11/2007 | Headed by Prof. Andre Keren, the center will operate within the heart institute at the Hadassah University Hospital in Ein-Kerem, Jerusalem. It will concentrate on strengthening follow up and treatment in the community. The goal of the center is to reduce, significantly, the need to hospitalize people with heart failure, to improve their quality of life and to extend their life expectancy. |
|
| Elie Douer and Family Center for Pediatric Genetic and Chronic Diseases Opened at Hadassah Mount Scopus | | 27/11/2007 | Hadassah's new Center for Pediatric Genetic and Chronic Diseases was dedicated in the name of Elie Douer and his family at an emotional ceremony at the Hadassah University Hospital on Mount Scopus. Fittingly, it took place in front of the Medical Center's Henrietta Szold Museum, which was open in honor of the occasion. Hadassah Mount Scopus director Prof. Zvi Stern, presiding over the ceremony, noted that the center's temporary premises had once stood at this site. Prof. Eitan Kerem, the director of the new center, shared his dream of establishing such a center, and described the15 years it had taken to bring it to life. Its purpose, he explained, is to provide comprehensive treatment for chronically ill children, as well as their anxious parents and siblings. |
|
| Hadassah's Innovative Treatment for Multiple Sclerosis: Transplanting Stem Cells from Patient's Bone Marrow | | 22/11/2007 |
A treatment developed at Hadassah, still in the research stage, has been tested on 25 multiple sclerosis and ALS (Lou Gehrig's Disease) patients. Professor Dimitrius Karussis, a senior neurologist at Hadassah and the director of the new Multiple Sclerosis Center, working in collaboration with the University of Athens, and Professor Shimon Slavin, the former director of the Department of Bone Marrow Transplantation (BMT) and the BMT Laboratory at Hadassah, discovered that it is possible to remove stem cells from a patient's bone marrow, to isolate these cells under special conditions and to generate over 50 million cells within two months. |
|
| Hadassah Study Documents High Prevalence of Depression | | 07/11/2007 | JERUSALEM, November 7, 2007 – A study by Dr. Michal Braun, psycho-oncologist at the Hadassah University Medical Center’s Sharett Institute of Oncology, documents previous anecdotal evidence – that cancer and its treatment have a profound impact on cancer patients’ significant others as well as on the patients themselves. The study scientifically documents the psychological and physical toll spouse caregivers experience and provides guidelines to identify those at risk. The Hadassah research was conducted in collaboration with Toronto’s Princess Margaret Hospital and the findings published in the current October issue of the Journal of Clinical Oncology. |
|
| Male Circumcision for HIV/AIDS Prevention | | 18/10/2007 | Responding to requests from several African countries, The Hadassah Medical Organization of Israel and the Jerusalem AIDS Project have teamed up to implement "Operation AB" – a medical and public health response to support scale up measures to enhance male circumcision (MC) services for HIV prevention in a number of interested countries Africa. |
|
| Nancy Falchuk elected as HWZOA 24th National President | | 20/07/2007 | 2500 delegates from all over the USA attended the annual Hadassah Convention, last July, in New York. They came to meet each other, receive information and updates on the myriad of Hadassah activities, look back at a very successful year and outline activities for the coming year. |
|
| Hadassah Successfully Preserves Hope For Fertility | | 06/07/2007 | Using the same process that adult female cancer patients can select, a multi-disciplinary team of Hadassah physicians has succeeded to obtain and freeze eggs from the ovarian tissue of young girls about to undergo chemotherapy, giving them hope to preserve their fertility. |
|
| Hadassah Demonstrates First of Its Kind "GPS" for Back Surgery | | 15/06/2007 | SpineAssist, a unique Israeli miniature robot for use in spinal surgery, was demonstrated for the first time at the Hadassah University Hospital-Mt. Scopus last week. The robot. developed by the Israeli company Mazor Surgical Technologies, is designed to assist surgeons in more precise implantation of screws and other devices necessary for successful spinal fusion procedures to treat lower back pain. Mazor developers refer to the miniature robot as a medical GPS system that brings surgeons to the requested address. |
|
| The Department of Neurology at the Hadassah University Medical Center Celebrates 70 | | 31/05/2007 | The Department of Neurology at the Hadassah University Medical Center Celebrates 70 !! An International Symposium with World Leading Neurologists will Mark the Occasion. The Symposium Will Honor Prof. Oded Abramsky who served as Head of the Department for 17 Years.
The department of neurology at the Hadassah University Medical Center in Jerusalem, will celebrate next week its 70th birthday. To mark this historic milestone, an international symposium on neurology will be held in Jerusalem next week (Sunday – Tuesday, June 3-5). Some 50 world leading neurologists and scientists will take part in the symposium, including Nobel Prize Laureates Prof. Aaron Ciechanover of the Technion, Haifa, Israel, and Prof. Stanley B. Prusiner of the University of San Francisco, California, USA. Participants will come from the USA, Canada, Scotland, Australia, Germany, Turkey, England, Greece, Sweden, Austria, Poland, Italy and Israel of course. |
|
| New traffic arrangements at the Hadassah Ein-Kerem campus | | 26/02/2007 | On Purim, 2012, the centennial of the founding of Hadassah, the Women's Zionist Organization of America, here in Jerusalem we will dedicate Hadassah's new Hospital Tower, which will completely alter our Ein-Kerem campus. This new 11-story facility, which will include all the inpatient departments, will be one of the most innovative and beautiful in Israel. A new parking building will be also constructed, adding some 1,000 parking spaces. |
|
| Helping People Help Themselves: An Instruction Kit for Coumadin Patients | | 28/01/2007 | Research and clinical trials have shown that instructing patients on how to use their medications produces positive long-term results, both emotionally and physically. The knowledge heightens their level of responsibility and has a significant impact on the effectiveness of their medication. "Empowering patients by having them participate in managing their medical treatment adds an important layer to the quality of their treatment,” says Prof. Mayer Brezis, head of the Center for Clinical Quality and Safety at the Hadassah University Medical Center. “The more information patients have and the greater role they take in managing their medical treatment, the more successful the outcome." |
|
| New Function of the Immune System Could Reduce Miscarriages Hadassah Breakthrough Released in Prestigious Scientific Journal | | 27/08/2006 | Jerusalem, August 3, 2006 – Upending conventional wisdom, which views the immune system’s primary function as destruction of foreign invaders, a team of Hadassah researchers has discovered that the immune system can also build.. This previously unknown function plays a major role in fetal development and pregnancy, with important implications for conditions that cause pre-eclampsia and miscarriages. Their breakthrough findings were published this week in Nature Medicene, the prestigious scientific journal. |
|
| Imposter to a doctor at Hadassah | | 21/02/2006 | The e-mails being sent by Dr. Cardello Ian are in no way connected to the Hadassah Medical Organization. Dr. Cardello is not on staff at Hadassah and does not represent Hadassah in any way. |
|
| Terror Once Again Strikes the Hadassah Family | | 24/07/2005 | Last night, around midnight shots were fired at a car in Gush Katif. The shots killed Rachel Kol, a Hadassah employee in the Neurology Laboratory for the last 20 years, and her husband, newspaper reporter and communications and public relations person Dov Kol. The two were returning from a family gathering at her sister’s home in Ganei Tal. |
|
| HIV/AIDS Breakthrough at Hadassah: A Therapeutic Vaccine that Complements the Cocktail | | 26/12/2004 | A Hadassah University Medical Center research team has developed a vaccine that significantly strengthens the body’s immune system against the autoimmune sequela of HIV infection, a breakthrough that could dramatically make an impact in the treatment of AIDS patients. It is now evident that although treatment with the cocktail of medications kills the virus, the immune system continues to kill healthy cells; this research focuses on developing a vaccine that would arrest this autoimmune destructive process. The results of this study were published in the latest issue of the prestigious Journal of Clinical Virology. |
|
| Hadassah and the Hebrew University to Establish a Biotech Park | | 17/11/2004 | The Hadassah Medical Organization and the Hebrew University, already partners in five schools of allied medical professions, have come together again to establish a biotechnology park at Hadassah Ein Kerem to provide incubator conditions for startup companies in the life sciences. |
|
| Biotech Bandage Promises New Success in Healing Wounds and Regenerating Tissue | | 12/10/2004 | Hapto-Biotech, an Israeli start-up company, and New York-based Ortec International Inc., have joined forces to develop a bandage capable of healing wounds and regenerating tissue, using a unique combination of peptides and collagen. The new technology could also have an important impact on orthopedic and dental procedures, as well as for the cosmetics industry. |
|
| Victims from Terror attack in Moscow brought to Hadassah for treatment | | 20/09/2004 | About three weeks ago, 31-year-old Igor Leib was seriously wounded in the chest during a terrorist attack in a Moscow subway station. On Sunday afternoon, Sept. 19th, he arrived at Hadassah-Ein Kerem for further medical treatment accompanied by his mother, who was also wounded in the attack, and his father. Leib and his mother Zoya, were examined thoroughly in the trauma unit before they were admitted to the department of surgery.
|
|
| Creative Cancer Killer Cell Therapy Only At Hadassah | | 25/07/2004 | At the inauguration of Hadassah's new day care center of the Sidney Weisner Department of Bone Marrow Transplantation and Cancer Immunotherapy today, Prof. Shimon Slavin, head of the department, described an innovative treatment for cancer patients who have previously undergone chemotherapy, surgery and/ or radiotherapy.
|
|
|
|
|
|
|
|